N-(2,4-Dimethoxyphenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide

Catalog No. :
ACLMOO666
CAS No. :
578756-18-0
Molecular Formula :
C20H23N3O4S2
Molecular Weight :
433.55

IUPAC Name:N-(2,4-dimethoxyphenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide

N-(2,4-Dimethoxyphenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,4-Dimethoxyphenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide
IUPAC NameN-(2,4-dimethoxyphenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide
Molecular FormulaC20H23N3O4S2
Molecular Weight433.55
SMILESO=C(NC1=CC=C(OC)C=C1OC)CSC2=NC3=C(C(C)=C(C)S3)C(N2CC)=O
InChI KeyJHGWIUAZGVVQAP-UHFFFAOYSA-N
SynonymSALOR-INT L412201-1EA;N-(2,4-DIMETHOXYPHENYL)-2-[(3-ETHYL-5,6-DIMETHYL-4-OXO-3,4-DIHYDROTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]ACETAMIDE;Acetamide, N-(2,4-dimethoxyphenyl)-2-[(3-ethyl-3,4-dihydro-5,6-dimethyl-4-oxothieno[2,3-d]pyrimidin-2-yl)thio]-
CAS No.578756-18-0

Synthetic Route by SureRoute

1. ACLMOO666 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACONSL354 route compound structure diagram
    ACONSL3542735-04-8 In Stock
  4. Then
  5. ACLMOO666 route product structure diagram
    ACLMOO666578756-18-0
Inquiry

2. ACLMOO666 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLMOO666 route product structure diagram
    ACLMOO666578756-18-0
Inquiry

Comments (0)